SUHA Pharma Consulting DMPK

Experience

Selected Project Experience

Representative capabilities. Client-identifying information and confidential data are not disclosed.

Preclinical PK Analysis

PK data processed and analyzed to generate concentration-time profiles, PK parameters, tables, figures and scientific interpretation.

Tissue Distribution & Excretion

Tissue-to-plasma ratios and urine, fecal and biliary recovery calculations to characterize compound disposition.

Translational PK

Allometric scaling and human exposure/dose prediction to support translational development planning.

PK Modeling & Simulation

Modeling and scenario simulations to explore exposure and dosing strategies.

Selected examples are representative of our capabilities. Client-identifying information and confidential data are not disclosed.